Editors-in-Chief
Junming Guo, Ningbo University, China
Junming Guo is the director of Department of Biochemistry and Molecular Biology at School of Medicine of Ningbo University and Zhejiang Provincial Key Laboratory of Pathophysiology. He received his B.M. degree from Nanchang University, Nanchang, China, and M.S. degree from Sun Yat-sen University of Medical Sciences, Guangzhou, China. He got his Ph. D. degree in Biochemistry and Molecular Biology from Sun Yat-sen University of Medical Sciences, Guangzhou, China. In 2005-2006, he worked as postdoctoral researcher at University of Minnesota, USA. He was promoted to Professor in 2000. His research interests have focused on the mechanisms of gastric cancer and its diagnosis, roles of noncoding RNAs in the occurrence and development of gastric cancer. He has published more than 160 journal articles (Total citations 5613, H-index 45).
Rong Fu, General Hospital of Tianjin Medical University, China
Rong Fu is a hematologist from General Hospital of Tianjin Medical University, vice-president of General Hospital of Tianjin Medical University, president of department of Hematology. She got her M.D. degree in the institute of hematology, Peking Union Medical College (PUMC) and Chinese Academic Medical Science (CAMS). Afterwards, she worked as postdoctoral researcher at Hong Kong University in 2004-2005. Then she worked as a Visiting scholar in Royal Melbourne Hospital in Australia from 2013 to 2014. In 1992, she joined General Hospital of Tianjin Medical University and was promoted to Professor in 2006. She has undertaken several professional services such as “Committee member of Chinese Society of Hematology” and “Chairman of Tianjin Medical Doctor Association of Hematology”. She is a recipient of several awards including “Medical Talents of Tianjin, 2018”, “Prize of Youth science, Tianjin, 2014)”, and “Prize of Natural Science (in Tianjin, 2010)”. She has published more than 70 refereed journal papers, several book chapters. Her research interests include:1) Pathogenesis of bone marrow failure diseases; and 2) Mechanism and treatment of hematological malignant disease, especially multiple myeloma, MDS and lymphoma.
Associate Editor
James L. Wittliff, University of Louisville, US
Jim Wittliff, a member of the original Editorial Board of JCLA, is Professor of Biochemistry & Molecular Genetics and Co-founder/Director of the Institute for Molecular Diversity & Drug Design. His team is internationally regarded for studies of estrogens and their mimics with receptor proteins in human cancer, exploiting proteomics and genomics. His laboratory was among the first to report estrogen receptors in a breast cancer biopsy predicted a patient’s response to hormone therapy. This finding led to collaborations with the NSABP, establishing Tamoxifen as adjuvant therapy for breast cancer and use of ER and PR as biomarkers of patient prognosis and therapeutic response. With NEN/DuPont, Dr. Wittliff developed the original FDA-approved kits for assessing estrogen and progestin receptors in biopsies, celebrated as a major contribution to laboratory medicine. Recent studies employ Laser Capture Microdissection to procure pure carcinoma cell populations and bioinformatics to decipher their genomics and proteomics to predict clinical behavior. Awards include Outstanding Contributions to Clinical Chemistry from the AACC where he was elected a Fellow of the Academy (FAACC) and the Goldsmith Research Excellence Award from the American Cancer Society.
Editorial Board
Jun Chen, Tianjin Medical University General Hospital, China Amitava Dasgupta, University of Texas, US Laurence M. Demers, The Pennsylvania State University, US Caigan Du, The University of British Columbia, Canada Chun-fang Gao, Shanghai Eastern Hepatobiliary Surgery Hospital, China Andrea Ferreira-Gonzalez, Virginia Commonwealth University, US Rongcai Jiang, Tianjin Medical University General Hospital, Tianjin, China Mark A. Jandreski, Siemens Healthcare Diagnostics, Inc., US Ming Liu, Tianjin Medical University General Hospital, China Junxuan (Johnny) Lu, Penn State College of Medicine, US Qishui Ou, Fujian Medical University, China Roger S. Riley, Virginia Commonwealth University, US Jeffrey Schlom, Center for Cancer Research, National Cancer Institute, US Xianrang Song, Shandong Cancer Hospital, China Gabriel Virella, Medical University of South Carolina, US Wenrong Xu, Jiangsu University, China Jun-Jun Wang, The General Hospital of Eastern Theater command, China Xianglin Wu, Mayo Clinic, US Jun Zhou, Nankai University, China
Publisher
Tina Wang, Wiley
Tina Wang received her Ph.D. degree in Biochemistry and Molecular Biology from Institute of Basic Medical Sciences, Peking Union Medical College in 2001 and finished her postdoctoral training in Department of Developmental Neurobiology, St. Jude Children’s Research Hospital in Memphis, Tennessee, United States before joining Wiley in 2011. At present, she is Journal Manager managing a portfolio of scientific journals in the subject areas of Life Sciences and Biomedical Sciences. Her responsibility also includes launching new open access journals in partnership with Chinese institutions.
|
京公网安备 11010802027423号